Could blackberry root tea help tame Graves' disease?
NCT ID NCT07164079
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a tea made from wild blackberry root could improve thyroid health in people with Graves' disease, an autoimmune condition that causes an overactive thyroid. Forty-two adults with newly diagnosed or relapsed Graves' disease drank either the blackberry root tea or a placebo tea every day for 8 weeks. Researchers measured thyroid hormones, autoimmune markers, and thyroid structure to see if the extract had any effect.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- wild blackberry root extract
- What this could lead to
- If it works, this could point toward a natural supplement to help manage Graves' disease alongside standard treatment.
- What could go wrong
- This is a small, early-stage study with only 42 people. The results may not apply to everyone, and the extract might not have a meaningful effect on the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
42 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with a new diagnosis of Graves' disease or those with a relapse of Graves' disease * Patients aged 18-65 * A score of 80 or higher on the Health Eating Index (HEI) Exclusion Criteria: * Having received treatment for the disease within the last 6 months * Having another chronic and/or autoimmune disease * Being pregnant or lactating
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Graves disease (basedow'S disease) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Muğla Sıtkı Koçman University/Muğla Training and Research Hospital Endocrine and Metabolic Diseases Polyclinic
Muğla, Mentese, 48000, Turkey (Türkiye)